Application of such details is limited by the early mother nature of your examine results. It's unclear if good recurrence-absolutely free survival outcomes in CheckMate 274 will translate into enhanced cancer-unique survival. Even though reaction rates to immune checkpoint inhibition in urothelial carcinoma is lower, people that obtain a reaction https://www.directivepublications.org/annals-of-urology/